LT3263B - Veterinary composition and process for preparing thereof - Google Patents

Veterinary composition and process for preparing thereof Download PDF

Info

Publication number
LT3263B
LT3263B LTIP1920A LTIP1920A LT3263B LT 3263 B LT3263 B LT 3263B LT IP1920 A LTIP1920 A LT IP1920A LT IP1920 A LTIP1920 A LT IP1920A LT 3263 B LT3263 B LT 3263B
Authority
LT
Lithuania
Prior art keywords
gel
dry
veterinary composition
coated
enteric
Prior art date
Application number
LTIP1920A
Other languages
English (en)
Lithuanian (lt)
Inventor
Stig-Goeran Arthur Olovson
Aake Gunnar Pilbrant
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LTIP1920A publication Critical patent/LTIP1920A/xx
Publication of LT3263B publication Critical patent/LT3263B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LTIP1920A 1993-04-30 1994-04-22 Veterinary composition and process for preparing thereof LT3263B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939301489A SE9301489D0 (sv) 1993-04-30 1993-04-30 Veterinary composition

Publications (2)

Publication Number Publication Date
LTIP1920A LTIP1920A (en) 1994-11-25
LT3263B true LT3263B (en) 1995-05-25

Family

ID=20389791

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1920A LT3263B (en) 1993-04-30 1994-04-22 Veterinary composition and process for preparing thereof

Country Status (33)

Country Link
US (1) US5731002A (de)
EP (1) EP0696921B1 (de)
JP (1) JP3872509B2 (de)
KR (1) KR100324451B1 (de)
CN (1) CN1100570C (de)
AT (1) ATE199060T1 (de)
AU (1) AU678830B2 (de)
BR (1) BR9406363A (de)
CZ (1) CZ285191B6 (de)
DE (1) DE69426669T2 (de)
DK (1) DK0696921T3 (de)
EE (1) EE03137B1 (de)
EG (1) EG20401A (de)
ES (1) ES2155473T3 (de)
FI (1) FI955124A0 (de)
GR (1) GR3035831T3 (de)
HR (1) HRP940267A2 (de)
HU (1) HUT74868A (de)
IL (1) IL109245A (de)
IS (1) IS1694B (de)
LT (1) LT3263B (de)
MA (1) MA23170A1 (de)
NO (1) NO312435B1 (de)
NZ (1) NZ265728A (de)
PL (1) PL176755B1 (de)
PT (1) PT696921E (de)
RU (1) RU2131267C1 (de)
SE (1) SE9301489D0 (de)
SG (1) SG52540A1 (de)
SK (1) SK280465B6 (de)
TN (1) TNSN94035A1 (de)
WO (1) WO1994025070A1 (de)
YU (1) YU22794A (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
CA2346646A1 (en) * 1998-10-06 2000-04-13 Mars Uk Limited Animal stereotypy
BR0008403A (pt) * 1999-02-23 2002-01-29 Merck & Co Inc Formulação farmacêutica para administração oral
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US20020064555A1 (en) * 2000-09-29 2002-05-30 Dan Cullen Proton pump inhibitor formulation
AU2002234545A1 (en) * 2000-12-07 2002-06-18 Byk Gulden Lomberg Chemische Fabrik G.M.B.H. Pharmaceutical preparation in the form of a suspension comprising an acid-labileactive ingredient
ES2375269T3 (es) * 2000-12-07 2012-02-28 Nycomed Gmbh Preparado farmacéutico en forma de una pasta que comprende un ingrediente activo l�?bil ante los �?cidos.
DE10061135C1 (de) * 2000-12-07 2002-11-07 Byk Gulden Lomberg Chem Fab Pharmazeutische Zubereitung in Form einer Paste enthaltend einen säurelabilen Wirkstoff
US20020192299A1 (en) * 2000-12-28 2002-12-19 Rajneesh Taneja Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US20040081671A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
MXPA05000301A (es) * 2002-07-03 2005-03-31 Abbott Lab Formas de dosificacion liquida de inhibidores de bomba de proton.
US20040006109A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
US20040005362A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20070243251A1 (en) * 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
US20040121004A1 (en) * 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
WO2004073654A2 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
ATE454906T1 (de) * 2003-07-11 2010-01-15 Astrazeneca Ab Feste zusammensetzung mit einem protonenpumpenhemmer
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
MXPA06000529A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulaciones farmaceuticas utiles para inhibir la secrecion de acido y metodos para elaborarlas y utilizarlas.
CA2531566C (en) * 2003-07-18 2013-05-07 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20050249806A1 (en) * 2004-02-10 2005-11-10 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
GB0403165D0 (en) * 2004-02-12 2004-03-17 Ct Novel uses for proton pump inhibitors
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
EP1698233A1 (de) * 2005-03-01 2006-09-06 Bayer HealthCare AG Verringerung der Aufnahmefähigkeit von Phosphor in der Tierernährung
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US20090068263A1 (en) * 2006-04-20 2009-03-12 Themis Laboratories Private Limited Multiple unit compositions
CH698658B1 (de) * 2006-04-24 2009-09-30 Mepha Ag Orale pharmazeutische Formulierung mit schneller Freisetzung für Pyridylmethylsulfinyl-Benzimidazole.
JP2009538901A (ja) * 2006-06-01 2009-11-12 デクセル ファーマ テクノロジーズ エルティーディー． 複式ユニット製薬的製剤
EP2046334B1 (de) 2006-07-25 2014-05-21 Vecta Ltd. Zusammensetzungen und verfahren zur hemmung von magensäuresekretion anhand von derivaten kleiner dicarbonsäuren in kombination mit ppi
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
JP5319691B2 (ja) * 2007-11-15 2013-10-16 ノバルティス アーゲー プラジカンテル、マクロライドラクトン、シクロデキストリンおよび粘稠化剤を含む駆虫ペースト
US20090227633A1 (en) * 2008-03-04 2009-09-10 Bassam Damaj Methods to inhibit tumor cell growth by using proton pump inhibitors
AU2012326513B2 (en) * 2011-10-19 2016-03-17 R.P. Scherer Technologies, Llc Two phase pharmaceutical delivery system
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
AU2016404808A1 (en) * 2016-04-29 2018-12-13 Alan Thompson Veterinary composition
CN107468652A (zh) * 2016-06-07 2017-12-15 北京新领先医药科技发展有限公司 一种固体干混悬温敏凝胶剂及其制备方法
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
AU2017310506B2 (en) * 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166287A1 (de) 1984-06-16 1986-01-02 Byk Gulden Lomberg Chemische Fabrik GmbH Dialkoxypyridine, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel
GB2163747B (en) 1984-08-31 1989-02-08 Nippon Chemiphar Co Benzimidazole derivatives, and antiulcer agents containing the same
EP0277741B1 (de) 1987-01-29 1992-09-09 Takeda Chemical Industries, Ltd. Kugelförmige Granula mit Kern sowie deren Herstellung
EP0519365A1 (de) 1991-06-17 1992-12-23 Byk Gulden Lomberg Chemische Fabrik GmbH Pantoprazol enthaltende orale Darreichungsformen
EP2479832A1 (de) 2009-09-18 2012-07-25 Asahi Glass Company, Limited Nichtwässriges elektrolyt für sekundärbatterien

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL22368A (en) * 1963-11-19 1969-01-29 Merck & Co Inc 2,5(or 6)-bis-heteroaryl substituted benzazoles
BE792990A (fr) * 1971-12-23 1973-06-19 Shell Int Research Procede de lutte contre les endoparasites chez les chevaux
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5215974A (en) * 1986-11-21 1993-06-01 Aktiebolaget Hassle Certain pyridyl[(methylthio- or methyl sulfinyl)-2 benzimidazol-2-yl]N-methyl phosphonates useful for treating gastric-acid secretion related diseases
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166287A1 (de) 1984-06-16 1986-01-02 Byk Gulden Lomberg Chemische Fabrik GmbH Dialkoxypyridine, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel
GB2163747B (en) 1984-08-31 1989-02-08 Nippon Chemiphar Co Benzimidazole derivatives, and antiulcer agents containing the same
EP0277741B1 (de) 1987-01-29 1992-09-09 Takeda Chemical Industries, Ltd. Kugelförmige Granula mit Kern sowie deren Herstellung
EP0519365A1 (de) 1991-06-17 1992-12-23 Byk Gulden Lomberg Chemische Fabrik GmbH Pantoprazol enthaltende orale Darreichungsformen
EP2479832A1 (de) 2009-09-18 2012-07-25 Asahi Glass Company, Limited Nichtwässriges elektrolyt für sekundärbatterien

Also Published As

Publication number Publication date
NZ265728A (en) 1996-12-20
NO954240D0 (no) 1995-10-23
CZ282595A3 (en) 1996-04-17
JPH08509493A (ja) 1996-10-08
HUT74868A (en) 1997-02-28
DE69426669D1 (de) 2001-03-15
EG20401A (en) 1999-02-28
DE69426669T2 (de) 2001-07-05
FI955124A7 (fi) 1995-10-27
ES2155473T3 (es) 2001-05-16
FI955124L (fi) 1995-10-27
LTIP1920A (en) 1994-11-25
HRP940267A2 (en) 1996-10-31
FI955124A0 (fi) 1995-10-27
SG52540A1 (en) 1998-09-28
CZ285191B6 (cs) 1999-06-16
BR9406363A (pt) 1996-02-27
SK280465B6 (sk) 2000-02-14
WO1994025070A1 (en) 1994-11-10
US5731002A (en) 1998-03-24
CN1100570C (zh) 2003-02-05
KR100324451B1 (ko) 2002-11-01
IL109245A (en) 2000-07-16
AU6693894A (en) 1994-11-21
PL176755B1 (pl) 1999-07-30
EE03137B1 (et) 1998-12-15
RU2131267C1 (ru) 1999-06-10
NO312435B1 (no) 2002-05-13
CN1122109A (zh) 1996-05-08
HU9503085D0 (en) 1995-12-28
PT696921E (pt) 2001-06-29
NO954240L (no) 1995-10-23
ATE199060T1 (de) 2001-02-15
DK0696921T3 (da) 2001-03-19
IS4146A (is) 1994-10-31
MA23170A1 (fr) 1994-12-31
TNSN94035A1 (fr) 1995-04-25
SK135495A3 (en) 1997-03-05
AU678830B2 (en) 1997-06-12
YU22794A (sh) 1998-05-15
EP0696921A1 (de) 1996-02-21
IS1694B (is) 1998-04-20
IL109245A0 (en) 1994-11-28
SE9301489D0 (sv) 1993-04-30
GR3035831T3 (en) 2001-08-31
PL311276A1 (en) 1996-02-05
JP3872509B2 (ja) 2007-01-24
EP0696921B1 (de) 2001-02-07

Similar Documents

Publication Publication Date Title
LT3263B (en) Veterinary composition and process for preparing thereof
EP1191926B1 (de) Neue omeprazole und (s)-omeprazole zusammensetzung
US6228400B1 (en) Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
RU95122630A (ru) Ветеринарная композиция, содержащая ингибитор протонных насосов
RS54699B1 (sr) Višečestične formulacije pantoprazola
CA2460987A1 (en) Pharmaceutical formulations for protecting pharmaceutical compound from acidic environments
CA2768024A1 (en) A stable pharmaceutical omeprazole formulation for oral administration
KR20020011990A (ko) 위액에 불용인 마이크로그래뉼, 이의 제조방법 및 약제
CA2408920C (en) Methods for prevention of ulcers and improving physiological performance
CA2161683C (en) Veterinary composition containing a proton pump inhibitor
WO2006026829A1 (en) Stable paste composition of enteric coated acid labile active agent and use thereof

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20010422